Merck's heavy reliance on Keytruda continues to grow, with the drug nearing 50% of total sales and limited growth from other products. Read why MRK is a Buy.

Many states rely on the federal government for the vast majority of their emergency management funding. Now, local leaders ...

Local leaders at Ethiopia’s largest community conservation area are working to become financially self-sufficient and ...

Broadcom is strategically positioned to capitalize on the next wave of AI-driven growth and infrastructure investment. Click ...

Nike stock jumps 15% after China shift, strong earnings beat, and CEO-led turnaround boost investor confidence.

Jilted, betrayed, dumped, or defiant. It’s hard to describe the European Union after relentless attacks from its once-dependable ally, the United States. The threat from Donald Trump’s second ...

Former President of Nigeria, Chief Olusegun Obasanjo, has stated that the country, like many other African nations, is hindered in its development due to its over-reliance on foreign assistance.

Nike is forecasting it will have to pay $1 billion in additional costs because of President Donald Trump’s tariffs, the ...

National Airspace System runs on antiquated technology while handling 45,000 daily flights. Upgrades need Senate OK of FAA ...

MK-0616, an experimental oral medication aimed at reducing LDL cholesterol, is intended to be the first oral PCSK9 inhibitor.

Reliance Industries Ltd. closed 5.77% below its 52-week high of 1,608.95 rupees, which the company reached on July 8th.

Donald Trump has proved no peacemaker. America’s entry into the Iran conflict has undermined the power of diplomacy.